Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
176.6 GBX | +0.06% | +0.17% | +8.95% |
May. 10 | StanChart exec sells shares; new Alphawave CFO buys | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 4.81B 6.15B | Sales 2025 * | 4.99B 6.38B | Capitalization | 1.89B 2.41B |
---|---|---|---|---|---|
Net income 2024 * | 152M 194M | Net income 2025 * | 163M 208M | EV / Sales 2024 * | 0.52 x |
Net Debt 2024 * | 618M 790M | Net Debt 2025 * | 505M 646M | EV / Sales 2025 * | 0.48 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
11.3
x | Employees | 50,000 |
Yield 2024 * |
2.26% | Yield 2025 * |
2.61% | Free-Float | 98.01% |
Latest transcript on Serco Group plc
1 day | +0.79% | ||
1 week | +0.74% | ||
Current month | -0.22% | ||
1 month | -2.63% | ||
3 months | -5.43% | ||
6 months | +11.91% | ||
Current year | +9.56% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 13-03-31 |
Nigel Crossley
DFI | Director of Finance/CFO | 61 | 13-12-31 |
Paul Checketts
IRC | Investor Relations Contact | - | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 13-03-31 |
Lynne Peacock
BRD | Director/Board Member | 70 | 17-06-30 |
John Rishton
CHM | Chairman | 66 | 16-09-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 176.6 | +0.06% | 1 204 562 |
24-06-05 | 176.5 | -0.62% | 1,341,082 |
24-06-04 | 177.6 | -1.00% | 1,936,535 |
24-06-03 | 179.4 | +0.79% | 2,092,669 |
24-05-31 | 178 | +0.96% | 5,041,104 |
Delayed Quote London S.E., June 06, 2024 at 03:44 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.56% | 2.41B | |
+13.80% | 69.59B | |
+6.55% | 17.32B | |
+24.97% | 14.04B | |
+8.98% | 13.39B | |
+16.82% | 10.16B | |
-22.38% | 6.65B | |
-4.35% | 5.98B | |
+3.58% | 5.28B | |
-4.38% | 4.79B |
- Stock Market
- Equities
- SRP Stock